tiprankstipranks

New Portfolio - New Portfolio

Joe Barnes

New Portfolio
Individual Investor
Ranked #420,984 out of 793,101 TipRanks' Investors
Success Rate
39%
59 out of 151
profitable transactions
Average Return
4.77%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 2.27%
6-Month Return▲ 0.95%
12-Month Return▼ 7.81%
YTD Return▲ 5.54%
Total Return▼ 8.44%

Best Trade

Opened at
Closed at-
Gain▲ 334.45%

Bio

My investment portfolio

Performance

26.01%0-26.01%
▼ 13.14%
▲ 2.34%
▼ 8.12%
Aug 2024
▲ 2.93%
▲ 2.10%
▲ 0.39%
Sep 2024
▲ 10.00%
▼ 0.89%
▼ 6.17%
Oct 2024
▲ 26.01%
▲ 5.96%
▲ 6.47%
Nov 2024
▲ 5.34%
▼ 2.41%
▼ 4.87%
Dec 2024
▲ 5.88%
▲ 2.69%
▲ 3.98%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 1.42%
Feb 2025
▲ 7.47%
▼ 3.09%
▲ 2.97%
Mar 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 13.14%▲ 2.34%▼ 8.12%
▲ 2.93%▲ 2.10%▲ 0.39%
▲ 10.00%▼ 0.89%▼ 6.17%
▲ 26.01%▲ 5.96%▲ 6.47%
▲ 5.34%▼ 2.41%▼ 4.87%
▲ 5.88%▲ 2.69%▲ 3.98%
▼ 12.86%▼ 1.27%▼ 1.42%
▲ 7.47%▼ 3.09%▲ 2.97%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
AT&T
0%
▲ 3.33%
1
Open
Mar 13, 2025
T Mobile US
0%
▼ 0.05%
1
Open
Mar 13, 2025
Marinus
▼ 94.54%
4
Close
Feb 10, 2025
Bellerophon
▼ 99.82%
4
Close
Dec 18, 2024
Applied Digital Corporation
0%
▼ 12.77%
1
Open
Nov 19, 2024
Pulmatrix
0%
▼ 5.77%
3
Open
Nov 17, 2024
BYD Company
0%
▲ 47.31%
1
Open
Nov 12, 2024
Devon Energy
11.11%
▼ 34.05%
16
Buy
Apr 06, 2024
Ardelyx
40.71%
▲ 39.44%
9
Buy
Jan 25, 2024
Oncolytics Biotech
0%
▼ 67.07%
1
Open
Jun 18, 2023
Immuneering
0%
▼ 84.76%
1
Open
Jun 18, 2023
Adverum Biotechnologies
0%
▼ 64.47%
1
Open
Jun 18, 2023
Carisma Therapeutics
0%
▼ 51.60%
3
Open
May 04, 2023
Nvidia
0%
▲ 153.26%
3
Open
Apr 03, 2023
Assertio Therapeutics
3.95%
▼ 84.83%
6
Sell
Mar 13, 2023
GlobalFoundries Inc
0.69%
▼ 31.21%
10
Sell
Mar 09, 2023
Citius Pharmaceuticals
0.01%
▲ 12.58%
5
Sell
Mar 09, 2023
Liquidia Technologies
0.27%
▲ 186.70%
16
Sell
Mar 09, 2023
Garrett Motion
0.15%
▲ 27.01%
8
Sell
Mar 09, 2023
Nine Energy Service
3.06%
▼ 70.78%
11
Sell
Jan 31, 2023